CREON (pancrelipase) Delayed-Release Capsules recall
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL…
Why was CREON (pancrelipase) Delayed-Release Capsules recalled?
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 1020156; Expiry: 3/31/2016
- Product
- CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL…
- Recalling firm
- AbbVie Inc
- Quantity
- 18,021 Bottles
- Distribution
- US: Nationwide
- Recall date
- October 8, 2014
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)